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Abstract Since the discovery of inducer cells as a separate
lineage for organogenesis of Peyer’s patches in the small
intestine of fetal mice, a lot of progress has been made in
understanding the molecular pathways involved in the
generation of lymphoid tissue and the maintenance of the
lymphoid architecture. The findings that inducer cells also
exist in adult mice and in humans, have a lineage
relationship to natural killer cells, and can be stimulated
during infections highlight their possible role in establish-
ing innate and adaptive immune responses. Novel concepts
in the development of intestinal lymphoid tissues have been
made in the past few years suggesting that lymphoid organs
are more plastic as previously thought and depend on
antigenic stimulation. In addition, the generation of novel
lymphoid organs in the gut under inflammatory conditions
indicates a function in chronic diseases. The present review
summarizes current knowledge on the basic framework of
signals required for developing lymphoid tissue under
normal and inflammatory conditions.
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Introduction
The gastrointestinal tract is continuously exposed to
antigens (Ags) and discrimination between pathogens and
commensal bacteria is achieved by the interaction of the
intestinal epithelium with lymphoid cells. Intestinal lym-
phoid cells can form organized cell aggregates called
Peyer’s patches (PP) where immune responses are initiated
leading to the generation of IgA-secreting plasma cells [1].
These sites belong to the mucosa-associated lymphoid
tissue (MALT), since they collect Ags from mucosal
surfaces. The epithelium overlaying the PPs forms the
interface between the MALT and the luminal microenvi-
ronment. It is critically involved in host defense and
maintenance of immune homeostasis through two major
pathways. Firstly, it contains specialized cells named M
cells able to transport luminal Ags to the PPs. Secondly, it
secretes antimicrobial products as well as cytokines, which
are essential for recruitment of immune cells to the Ag
entry site. The commensal and pathogenic microorganisms
in the luminal content engage innate receptors expressed by
intestinal epithelial cells. As a consequence, epithelial
cytokines and activated dendritic cells (DCs) regulate the
quality of adaptive immune responses leading to either
tolerance or immunity.
In addition to PPs, the lamina propria of the murine gut
contains multiple small cryptopatches (CPs), which can
emerge into isolated lymphoid follicles (ILFs) in response
to the gut flora [2, 3]. Whereas the number and localization
of PPs is developmentally fixed before birth, CPs and ILFs
represent the most dynamic compartments of the small
intestine, since they develop after birth and number and size
are highly variable, depending on the bacterial load [3].
ILFs were shown to be alternative sites of generating IgA
responses [4].
The process of lymphoid tissue induction in the gut
depends on two mutually nonexclusive pathways, including
(1) tumor necrosis factor super family member signals
provided by hematopoietic cells and (2) innate signals
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through toll-like receptors (TLRs) and proinflammatory
cytokines leading to the expression of lymphoid chemo-
kines and adhesion molecules. In fetal mice, a particular
subset of hematopoietic cells was identified, which is
indispensable for the development of secondary lymphoid
organs (SLOs) [5, 6]. These cells engage lymphotoxin β
receptor (LTβR) on stromal cells followed by the produc-
tion of chemokines that recruit T and B cells. In adult mice,
similar cell subsets might exist, which, together with mature
lymphocytes and proinflammatory cytokines, contribute to
shaping of preexisting lymphoid organs. In addition, novel
lymphoid tissues can form within organs during chronic
inflammation and autoimmune diseases [7, 8]. The cellular
architecture of these tissues is reminiscent to the T and B
cell compartments seen in SLOs.
In this chapter, we attempt to compare the pathways,
which lead to the formation of intestinal lymphoid organs
(a) before birth, (b) upon antigenic challenge, and (c)
during chronic inflammation. We discuss the contribution
of lymphoid tissue inducer cells, lymphocytes, and intesti-
nal bacteria to the development and maturation of intestinal
lymphoid organs in mouse and man and emphasize on the
role of intestinal lymphoid organs for the development of
inflammatory bowel disease (IBD).
Intestinal lymphoid organs in mouse and man
Organized lymphoid microenvironments in the gut
Organized lymphoid aggregates in the gut represent the
primary sites for eliciting adaptive immune responses
toward mucosal Ags. Joseph Hans Conrad Peyer, a Swiss
anatomist and physician (1653–1712), described for the
first time PPs as the most prominent organized SLOs of the
small intestine, with greatest density in the ileum. In
humans, they emerge as follicles localized in the antime-
senteric border of the gut at week 19 of gestation [9]. In
contrast to lymph nodes (LNs), PPs are not connected to
afferent lymphatic vessels draining Ag entry sites. Instead,
they are overlaid by a follicle-associated epithelium (FAE),
which is specialized to uptake luminal microorganisms and
Ags. The development of PPs is related to age, and number
and size is at maximum at puberty and involutes upon
aging [10]. Studies in other species reveal that jejunal and
ileal PPs differ in their capacity to mount an immune
response, to export lymphocytes via efferent lymphatic
vessels and to produce cytokines [11–13]. Like other SLO,
PPs are composed of segregated B and T cell zones, which
form in an Ag-independent manner [14] (Fig. 1a). Unlike
LNs, where T cells are mainly found in the paracortex, PP T
cells localize in T cell zones between B cell follicles
(Fig. 1b). The subepithelial dome (SD) of PPs contains two
distinct subsets of DCs [15] that are distinguished by the
expression of either CX3CR1 or CCR6 [16] (Fig. 2). The
CX3CR1 DCs appear to be noninflammatory residual DCs
collecting Ag from the luminal site under homeostatic
conditions. These cells are likely identical to intraepithelial
CD11b− CD8α− DCs that were found within the FAE and
in the interfollicular region (IFR) [17]. A third subset of
DCs localizes to the IFR that is CD11b− and CD8α+. DCs
are the key players in eliciting primary immune responses,
as in the absence of DCs specific T cell responses in PPs
are impaired [16]. Moreover, under pathogen-free condi-
tion, DCs are the dominant subset of cells underneath the
FAE, whereas B and T cells only enter the subepithelial
dome after colonization with bacteria [18]. Most of the
mucosal IgA Abs are produced by germinal center (GC) B
cells found in PPs of the intestine. The formation of GCs
requires the activation of T helper cells by Ag-loaded DCs,
the cognate interaction between activated T cells and Ag-
specific B cells, and the presence of follicular CD4+ T
helper (Th) cells (Fig. 1b). These follicular Th cells can be
generated from Foxp3+ CD4+ T cells demonstrating an
unexpected link between Tregs and GC formation [19].
TGF-β, Il4, Il6, and Il10 are locally synthesized in PPs and
help to trigger B cell responses and expand IgA-secreting
plasma cells [20]. Although PPs represent an important site
for the induction of mucosal immune responses, in PP-
deficient mice, a surprising capacity of generating oral
Fig. 1 a Peyer’s patch in mouse
small intestine. b Immunohisto-
chemistry of Peyer’s patch using
antimouse CD4 (green) and
antimouse CD11c (red) Ab
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tolerance and producing intestinal IgA responses was
uncovered suggesting alternative sites for inducing adaptive
immune responses. These sites were identified as multiple
lymphoid aggregates called ILF scattered throughout the
entire small intestine and colon, with the highest abundance
in the distal ileum [21, 22] (Fig. 3a). Unlike PPs, they
develop only after colonization of the gut with bacteria and
represent highly dynamic lymphoid structures, which can
vary in number and size [21]. ILF are composed of a single
B cell follicle, surrounded by DCs, T cells, and Il7r+ c-kit+
cells, the latter one closely localized to the subepithelial
dome [21, 23] (Fig. 3b). They are overlain by an FAE, can
uptake Ag, and generate GCs, a fact that drew them into
attention as inductive sites for immune responses [24, 25].
Beside ILFs, smaller lymphoid structures named crypto-
patches (CPs) are scattered throughout the intestine [26].
They appear 1 to 2 weeks after birth and, in contrast to
ILFs, localize to the bottom of crypt areas and barely
contain B and T cells [26]. In contrast to ILFs, the presence
of CPs has so far only been described in mice, but CPs are
absent from the small intestine in humans, rats, and pigs
[27]. Morphological intermediates between CPs and ILFs
suggest that CPs can mature into ILFs [27].
Follicle-associated epithelium and M cells
The SD region of PPs is covered by the FAE, which is
defined by its high density of specialized Ag-sampling cells
called membrane or microfold (M) cells [28]. In addition,
the FAE is, unlike the villus epithelium, not underlain by
subepithelial myofibroblasts and goblet cells are almost
absent [29]. M cells lack an absorptive capability, have only
poorly organized short brush-border microfilli, and do not
produce enzymes with digestive activity. Hence, alkaline
phosphatase and sucrase-isomaltase, which are typical for
enterocytes, were both used as negative markers of M cells
[30]. M cells have an enormous propensity of transcytosis
of Ags and particles from the luminal side of the gut. One
characteristic of M cells is that they form large invaginated
pockets harboring lymphocytes and DCs. This facilitates
the contact between the incoming Ag and the adaptive
immune system. There is strong evidence that the viral and
bacterial uptake of M cells is receptor-mediated [31, 32].
Pattern recognition receptors on the surface of M cells have
been identified as important receptors including TLR4,
platelet-activating factor receptor, and α5β1 integrin [32].
The engagement of TLRs can stimulate the microparticle
uptake and recruitment of DCs [33, 34]. In addition, the
number of M cells increases in germ-free mice upon
bacterial stimulation reflecting the dynamic of shaping intes-
tinal microcompartments through environmental changes
[35]. It is therefore likely that upon intestinal infection,
inflammatory signals promote the generation and activation
of M cells thereby increasing the efficiency of transcytosis
and recruitment of DCs to the subepithelial dome. These
DCs induce Ab isotype switching in B cells from IgM to
IgA through their secretion of Il6 and expression of retinal
dehydrogenases, the enzymes required for the generation of
retinoid acid from vitamin A [36, 37].
Studies in rabbits and humans have shown that the FAE
does not express the polymeric Ig receptor or secretory
component, the cleaved extracellular domain of the poly-
meric Ig receptor [38, 39]. Secretory IgA (SIgA), however,
exhibits a striking affinity to M cells in mouse and man
Fig. 2 Dendritic cell subpopulations in Peyer’s patch. SD subepithe-
lial dome, FAE follicle-associated epithelium, IFR interfollicular
region, DC dendritic cell
Fig. 3 a Immunohistochemistry
with anti-CD45 (green) Ab of
small intestine and b organiza-
tion of isolated lymphoid
follicles
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FAE [40], and immune complexes of SIgA and bacteria can
translocate to SD DCs via M cells [41] thereby eliciting an
immune response in PPs. SIgA might not only absorb
microorganism and Ags in the intestinal lumen but also
direct them specifically to M cells thereby allowing uptake,
processing, and presentation in lymphoid organs. Under
noninflammatory conditions, steady-state Ag acquisition of
luminal content including commensal bacteria and cell
debris may favor tolerance induction.
Using microarray analysis and in situ hybridization,
various genes have been identified that were restricted to
mouse, macaque, or human FAE [42–46]. These studies
clarified that some but not all genes expressed by the FAE
were unique for M cells. The FAE harbors to date poorly
investigated subsets of epithelial cells that differ in their
genetic profile from the normal villus epithelium and from
M cells. Whether these cells represent predetermined M cell
precursors that can become fully-functional Ag-sampling
cells upon microbial stimulation remains to be investigated.
In mice, the FAE of the small intestine constitutively
expresses the chemokines CCL9 [47] and CCL20 (Mip3α)
[15, 48], whereas in humans, CCL20 is also expressed in
colonic epithelial cells [49]. CCL20 is chemotactic for cells
expressing the corresponding chemokine receptor CCR6
such as γδ T cells, memory T cell subsets, B cells, and
myeloid CD11b+ DCs subpopulations [15, 50–53]. Under
inflammatory conditions, normal enterocytes can produce
CCL20 as well [54] reconciling the concept that intestinal
epithelial cells are highly plastic and can connect the innate
and adaptive immune system through recruiting CCR6-
expressing DCs and lymphocytes to sites of inflammation.
Although it was reported that CCR6−/− mice had a
perturbed intestinal immune system [16, 55] and a reduced
number of M cells [56], investigation of various CCR6−/−
mice revealed a relatively normal ratio of subepithelial DCs
and lymphocytes [47, 56]. This would suggest that other
FAE-specific chemokines such as CCL9 could compensate
for the lack of CCR6 or, alternatively, that some SD DCs
are independent of CCR6, whereas others are recruited
through CCR6 and inflammatory signals as previously
proposed [16].
There are two models explaining the differentiation of
the FAE and the origin of M cells (Fig. 4). One model
proposes that the FAE develops from the crypts surround-
ing the PP anlage. Stem cells reside within the crypts and
give rise to progressively differentiating absorptive enter-
ocytes and mucous cells, which migrate up toward the tip
of the villi, where they are shed a few days later [57]. The
follicle-associated crypts might contain stem cells, which
have to give rise to cells migrating in two different axis. On
one side, crypt stem cells differentiate into absorptive
enterocytes, goblet cells, and enteroendocrine cells. On
the other side of the crypt wall, cells give rise to the FAE
containing M cells. The stem cells that can give rise to the
FAE or the specific differentiation program, which is
required to coordinate the development of the two axes,
has not been identified so far. Alternatively, it was proposed
that M cells can be generated through conversion of
enterocytes upon contact with underlying lymphocytes.
This hypothesis was supported by an in vitro assay
demonstrating for the first time that human enterocyte cell
lines cultured in the presence of B cells could be converted
into M cells [58]. This model was further developed by
adding PP cells to human or mouse epithelial cell lines [59,
60]. In these studies, however, human adenocarcinoma cells
(Caco-2) were used that might not behave like conventional
enterocytes. In addition, the appearance of M-like cells was
reported to occur in Caco-2 cells even in the absence of
lymphocytes [61]. Although in vitro and in vivo studies
using B cell-deficient mice have let to the conclusion that B
lymphocytes play a role for M cell conversion [58, 62],
RAG-1−/− mice develop small but detectable PPs with M-
cell harboring FAE indicating that M cells can develop in
the absence of lymphocytes [63]. This is also confirmed in
SCID mice, which lack B and T lymphocytes but develop
detectable PP anlagen [64]. It is likely that in the absence of
lymphocytes, M cells can develop but that a mature FAE
depends on the presence of lymphocytes. The reconstitution
of immunodeficient mice with WT bone marrow (BM)
enlarges preexisting PP anlagen and may promote the
maturation of the FAE [65]. Since an early appearance of M
cell markers was already detected in the vicinity of the
follicle-facing crypts [66], factors produced by underlying
lymphocytes must act very early in the differentiation of
crypt cells. Altogether, we think that the development of M
cells is a result of commitment from particular progenitor
cells, the interaction of progenitor cells with lymphocytes
and contact with microbial Ags.
The paradigm of a specialized FAE required for Ag
uptake has become challenged by more recent findings that
single M cells are also found along the villus axis in normal
and PP-deficient mice [67]. Moreover, CCL20 expression
can be extended to normal enterocytes upon stimulation
with flagellin [54] suggesting that inflamed enterocytes can
Fig. 4 Models of M cell development
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adopt “FAE-like” features. The discovery of M cells in the
villus epithelium [67] together with the fact that a
specialized subset of CX3CR1+ lamina propria DCs can
form transepithelial dendrites to uptake luminal Ag [68, 69]
suggest that efficient Ag uptake does not only occur in
organized lymphoid aggregates.
Stromal cell networks in the intestine
It is well established that stromal cells not only have an
essential role in generating a lymphoid tissue architecture
but are also required for adaptive immune responses. For
example, PP stromal cells secrete factors such as TGFβ1,
Il6, and Il10, which promotes the differentiation of Ag-
stimulated B cells into IgA-producing plasma cells. In
addition, lymphoid stroma cells secrete BAFF, SCF, and
Il7, which may enhance the survival of B and T cells and
class switching of Igs. Various subsets of stromal cells in
the gut-associated lymphoid tissue (GALT) were identified
which exert different functions in the intestinal immune
system. In PPs, CPs and ILFs of adult mice, vascular cell
adhesion molecule-1 (VCAM-1)+ stromal cells are detect-
able around the periphery and within B cell areas, a pattern
reminiscent of follicular dendritic cells (FDCs) [70]. FDCs
are of mesenchymal origin and, in addition to VCAM-1 and
LTβR, express complement receptors 1 (CD35) and 2
(CD21) and the FcγRIIb, which allow the trapping of
immune complexes and retention of Ag. The display of Ag,
the production of B cell growth factors, and the secretion of
chemokines support the activation and differentiation of
follicular B cells and the generation of GCs. It is generally
accepted that B cells, lymphotoxin, and tumor necrosis
factor (TNF) are required for FDC development and
organization of T/B zones [71]. The loss of LTβ expression
in gene-targeted mice reveals a direct correlation between
the level of organization and immunosurveillance.
In LNs, the T cell zone consists of gp38+ VCAM-1+
stromal cells, which form a three-dimensional network of
cells and fibers [72, 73]. These fibroblast reticular cells
(FRCs) produce Il7 which has a key function in T cell
homeostasis and function [74]. Moreover, LN FRCs create
the conduit system consisting of a sheet of FRCs around
reticular fibers and extracellular matrix proteins [75–77].
The conduit and fiber network can be identified by ER-TR7
immunohistochemistry. The conduits are coated with
various chemokines, which allow the distribution and
locomotion of DCs and lymphocytes attaching to the FDC
fibers [78]. It is currently unknown if similar network of
ER-TR7+ conduits exist in PPs and ILFs that may regulate
lymphocyte trafficking in intestinal lymphoid tissues.
The recruitment of lymphocytes is coordinated by
chemokines produced by stromal cells such as FDCs,
FRCs, endothelial cells, and perivascular myofibroblasts.
Naïve lymphocytes leave the circulation and enter SLOs via
high endothelial venules (HEVs). CXCL13 produced by
FDCs localizes incoming B cells to the follicular zone, and
in the T zone, FRCs express CCL19 and CCL21 that
recruits T cells [79]. In contrast to mouse PP, in which HEV
produce CCL21, HEVs in human PPs lack detectable
CCL21 transcripts, although CCL21 protein is readily
detectable [80]. One possible explanation was provided by
another study demonstrating that HEVs possess basolateral
binding sites for CCL19 [81]. This indicates that trans-
cytosis of chemokines through endothelial cells may be
responsible for attracting naïve CCR7+ T cells to human
PPs. It is conceivable that HEVs have a capacity of
transcytosis similar to the aforementioned M cells in the
FAE.
In addition to regulating migration and survival of
lymphocytes, under homeostatic conditions, stromal cells
can potentially contribute to the induction of peripheral
tolerance. LN stromal cells express autoimmune regulator
(AIRE) [82], the regulator of promiscuous gene expression.
They help generating regulatory DCs [83] and produce the
vitamin A metabolite retinoid acid (RA), a key molecule in
generating gut-homing T cells and intestinal Foxp3+ Tregs
[84]. Whether stromal cells support Ag-specific immune
responses or rather tolerance induction might depend on
additional inflammatory signals provided by the innate
immune system.
Stromal cells are also active players in the initiation of
lymphoid tissue development (see also “Regulation of
Peyer’s patch development during fetal life” section). In
PP and LN anlagen of fetal mice, mesenchymal stromal
cells named “organizer cells” express LTβR, VCAM-1,
intercellular adhesion molecule 1 (ICAM-1), and mucosal
vascular addressin cell adhesion molecule 1 (MAdCAM-1).
The gene expression profile of organizer cells isolated from
PP anlagen differs from mesenteric LN organizer cells [85].
This is consistent with the notion that PP and LN
development requires the activity of different genes.
Recently, LTβR+ VCAM-1+ ICAM-1+ MAdCAM-1+ cells
designated as marginal reticular cells (MRC) were identi-
fied in adult SLO [86]. Interestingly, MRCs were localized
in the subepithelial dome of PPs, the marginal zone of the
spleen, and underneath the subcortical sinus of LNs. These
are the sites where Ag enters lymphoid tissues. It will be
important to study if MRCs have a role for recruiting DCs
or coordinating immune responses upon Ag entry.
Regulation of Peyer’s patch development
during fetal life
PP development has been extensively studied in various
animal models. One of the first fundamental discoveries
Semin Immunopathol (2009) 31:151–169 155
toward understanding the molecular events driving PP
organogenesis was the finding that mice with a mutation
of alymphoplasia (aly) were completely devoid of PPs and
LNs [87]. The aly allele encoded a single mutation in the C-
terminal interaction domain of NF-κB-inducing kinase
(NIK) [88, 89], a signaling molecule of the LTβR. A
phenotype similar to the aly mutation was found in mice
with a deletion of LTα, a TNF superfamily chain, which
can associate to LTβ thereby forming a heterodimeric
ligand for LTβR [90]. Moreover, a deletion of NIK resulted
in loss of PPs and LNs [91]. When LTβR−/− mice were
analyzed, PPs were found to be absent [92, 93]. Altogether,
these data highlight the importance of LTβR and its
downstream signaling molecules for the development of
PPs during fetal life.
Studies in the last 10 years have led to the paradigm that
in mice, at least two cell types act as key players in PP
development: hematopoietic LTαβ+ Il7r+ c-kit+ CD4+ lin−
cells [64, 94, 95], named lymphoid tissue inducer (LTi)
cells and mesenchymal LTβR+ VCAM-1+ ICAM-1+ orga-
nizer cells [96, 97]. Both cell subsets express corresponding
adhesion molecules and cytokine receptor/ligand pairs,
which enable them to attach to each other and form cellular
aggregates forming the primordium of PPs. LTi cells
colonize the developing gut at E12.5 of gestation [98].
Since they mainly localize to blood vessels, it is likely that
the entry site for LTi cells is the vascular endothelium. In
addition to the developing gut, LTi cells migrate to putative
sites of LN formation, to the fetal spleen, and, as recently
reported, to the fetal thymus [99]. In developing primary
and secondary lymphoid organs, they have specific but
probably diverse functions dependent on which cellular
partner they engage.
LTi cells express the nuclear hormone receptor RORγt
[98] as well as a number of TNF superfamily member
molecules (LTα1β2, LIGHT, TNF-α, RANK, DR3, 4-1BB)
[95, 100, 101], among them LTα1β2 can engage LTβR
expressed on the surface of organizer cells [97] (Fig. 5).
The adhesion of LTi cells to organizer cells is coordinated
by activation of α4β1-integrin on LTi cells, the high
affinity ligand of VCAM-1 [102]. Moreover, LTi cells
express α4β7, which can bind to MAdCAM-1 expressed
by the organizer cells. After attachment, signaling via
LTβR leads to the expression of chemokines and adhesion
molecules that are involved in lympho-organogenesis [103–
105]. The production of CCL19, CCL21, and CXCL13
probably helps to recruit more LTi cells, since they express
the corresponding chemokine receptors CCR7 and CXCR5
[97, 101]. In addition, these chemokines promote the
colonization of PPs with lymphocytes. It is possible that
LTi cells not only engage LTβR on the surface of organizer
cells but also on endothelial cells before entering the
parenchyma. The activation of endothelial LTβR is re-
quired for the formation of HEVand for the development of
lymphatic vessels [106–108]. Finally, LTi cells can trigger
LTβR signaling in epithelial cells, which is an important
step for CCL20 expression and maturation of the FAE
[109] (Fig. 5). The local release of Il7 by enterocytes and
organizer cells might help to maintain the pool of LTi cells
through anti-apoptotic signals.
It is surprising that in LTα−/− mice treated with an
agonist anti-LTβR Ab from E13 onward, unlike some LNs,
the formation of PPs could not be restored [110]. These
data suggest that either the threshold of LTβR signals
required for PP development exceed LN development or,
alternatively, that additional signals are required for PP
development. The latter explanation is supported by the
observation that in some mouse models with a null
mutation for TNFRI (TNFp55), PP formation is abrogated
[111, 112]. Although treatment of pregnant mice with the
TNFRp55-Ig fusion protein failed to block PP development
in the offspring, it substantially suppressed the proportion
of organizer cells [97]. TNFα can activate both TNFRI and
TNFRII. Since TNFRII−/− mice have normal PPs, TNFRI
together with LTβR seem to be the major receptors
triggering the expression of genes involved in PP develop-
ment. There is indeed evidence for a synergistic activity of
TNFRI and LTβR signaling in mesenteric LN genesis
[113]. TNF can induce LTαβ expression by LTi cells [114],
and therefore, the local release of TNF may indirectly
promote the engagement of LTβR. A relative increase in
the amount of TNFα together with LTαβ was found in fetal
as compared to adult LNs [115] and this may contribute to
lympho-organogenesis during fetal life. Altogether, despite
the essential role of LTβR for the development of PPs and
LNs, this pathway alone is not sufficient to induce
organogenesis. The identification of additional signals
triggered by early fetal hematopoietic cells will be a matter
of future investigations in order to better understand the
requirements for lymphoid organ development.
Fig. 5 Development of Peyer’s patches and FAE through engagement
of LTβR. LTi lymphoid tissue inducer cell, MC mesenchymal cell, EC
epithelial cell
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Signaling via the heterodimeric Il7r complex composed
of the IL-7Rα and the common γ chain (γc) is the
canonical cytokine pathway for the development of PPs
and LNs [116]. Despite that, there is evidence that
additional cytokines may contribute to PP and LN
development. For example, mice double deficient in the
fms-like tyrosine kinase-3 (flt3) ligand and IL-7Rα show
further impairment in the development of LNs and PPs
[117]. Il7−/− mice have normal numbers of PP anlagen,
whereas mice having a null mutation of IL-7Rα, γc, or
JAK3, a kinase involved in the Il7r-signaling pathway, are
completely devoid of PP anlagen [6, 94, 118–121]. This
could potentially reflect the action of one or more
alternative ligands promoting organogenesis in the fetal
intestine. The Il7-like cytokine thymic stromal lympho-
poietin (TSLP) binds to a heterochimeric receptor com-
posed of IL-7Rα and a receptor subunit called TSLPR
[122, 123]. Both Il7 and TSLP are constitutively expressed
by intestinal epithelial cells (Fig. 5). TSLPR−/− mice have
no defect in PP development [124] emphasizing the
commanding role of Il7r in organogenesis. Therefore,
alternative ligands regulating PP anlagen formation in fetal
Il7−/− mice remain to be identified. A collaboration of
signals regulating lympho-organogenesis was also proposed
for IL-7Rα, CXCL13, and CCR7 [120] as well as for IL-
7Rα and TRAF6 [114]. Mice deficient for CCR7, CCL19,
or CCL21 have a normal phenotype with respect to SLO
development [125, 126]. By combining the ablation of
CXCR5 and CCR7, peripheral LN numbers were severely
reduced, although PP numbers were almost normal [127].
These observations are in agreement with findings that the
combinatorial interactions between two or more cytokines
are frequently required for development and differentiation
[128]. The collaboration of chemokines, cytokines, and
adhesion molecules might promote the entry and accumu-
lation of LTi cells, as well as their survival, expansion, and
expression of LTαβ in the fetal gut.
Despite substantial knowledge on the molecular path-
ways that are involved in lympho-organogenesis, the
sequence of inductive events in PP ontogeny and the
cellular requirements to generate PPs are still not fully
understood. At the early stages, PP anlagen appear as
cluster of VCAM-1+ organizer cells in the proximal
jejunum at E15.5 [64] before they extent to the distal part
of the gut. One to 2 days after VCAM-1+ spots have
emerged, LTi cell cluster are detectable at the same
location. The formation of organizer cluster does not occur
cell autonomously, as the lack of LTi cells in RORγ−/−
mice, the Ab-mediated neutralization of IL-7Rα, or the
deletion of LTα prevents PP anlagen formation. These data
suggest that few LTαβ-expressing LTi cells are sufficient to
initiate PP anlagen formation before LTi cell cluster are
detectable. Il7 has a major role in inducing LTαβ
expression on LTi cells [95, 114, 129]. Hence, the
neutralizing activity of α-IL-7Rα Ab treatment may rely
on insufficient expression of LTαβ. This is further
supported by the fact that the migration of LTi cells to the
intestine is maintained in the absence of IL-7Rα or LTαβ,
although the cells are only scattered [94]. It is likely that
after entering the gut via capillaries discharging into the
antimesenteric wall of the gut, single LTi cells require
stimulation by Il7 in the intestine in order to express high
levels of LTαβ and activate mesenchymal organizer cells.
In a second step, VCAM-1 is upregulated by organizer cells
that were previously exposed to incoming LTi cells. The
formation of organizer cluster is then a consequence of
LTβR signals activating neighboring VCAM-1− organizer
cells according to the concentration of LTi cells. Alterna-
tively, VCAM-1+ organizer cell cluster are a result of
proliferation and/or migration of VCAM-1+ cells. This
would, however, not explain why LTα−/− mice are
completely devoid of single VCAM-1+ cells. In a final
step, the chemokine-driven reinforced influx of LTi cells
might lead to the formation of detectable LTi cell cluster.
We demonstrated the dependence of organizer cluster
formation on LTi cells in two mouse models with increased
number of LTi cells. In one model, the adoptive transfer of
LTi cells was able to restore organizer cell cluster in
CXCR5−/− mice [102]. In the other model, a striking
increase in the absolute cell number of organizer cells was
observed in mice expressing Il7 transgene (tg) under the
control of an ubiquitous promoter [129]. Il7 tg expression
increased both the absolute cell number and LTαβ
expression of LTi cells in fetal mice. Accordingly, a
continuous band of VCAM-1+ organizer cells accumulated
in the antimesenteric wall at E16.5 demonstrating for the
first time that there is no positional signal for PP anlagen
formation. At birth, however, this band of organizer cells
gave way to multiple clusters along the entire intestine. The
mechanism for this pattern formation is still unsolved.
Nishikawa et al. proposed that analogously to the reaction–
diffusion paradigm in other biological systems, inhibitory
signals interfere with activation signals coming from LTi
and organizer cells and result in a periodic pattern [6, 130].
For example, cytokine signals may be modulated by
inhibitory soluble cytokine receptors or suppressors of
cytokine signaling [131, 132]. Altogether, a model has
evolved where PP anlagen are formed as soon as LTi cells
and organizer cells assemble [6].
Together with the abundance of LTi cells in the fetal gut,
numerous CD11c+ cells are found scattering over the gut
[64, 95]. At E17.5, CD11c+ cells are mainly localized in the
periphery of PPs but eventually fuse to LTi cell cluster after
birth [96]. This cell subset was recently characterized in
more detail [133]. The cells are of hematopoietic origin,
express CD11b, CCR7, c-kit, and high levels of LTαβ, but
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are negative for CD4, CD3, CXCR5, and IL-7Rα. [96]. In
contrast to conventional DCs, they lack DEC205, but
express Gr-1 and NK1.1. Forty percent of these cells
express RET, a receptor tyrosine kinase involved in the
formation of the enteric nervous system. The corresponding
ligand artemin (artn) is expressed by intestinal VCAM-1+
cells, which include mesenchymal organizer cells and
endothelial cells. Artn was found to promote the recruit-
ment of LTi cells and CD11c+ cells in vitro. Mice with a
deletion or hypomorphic allele of RET had a reduced
number of PP anlagen suggesting that the RET/Artn axis
has a role in gut lymphoid tissue development. It remains to
be studied if the number and activity of RET CD11c+ cells
is normal in mouse models such as IL-7Rα−/−, RORγ−/−,
and Id2−/− mice. Altogether, TNFRI, LTβR, Il7r, and RET
are instrumental in PP development. The availability of Il7
determines the number and activity of LTi cells thereby
influencing the size of the pool of VCAM-1+ organizer
cells and PP anlagen.
Origin, life cycle, and fate of LTi cells in mouse and man
LTi cells are present in RAG−/−, scid, and nude mice
indicating that they do not need RAG recombination or a
thymus for their development. However, the generation of
conventional LTi cells is strictly dependent on the expres-
sion of the retinoid acid-related orphane receptor RORγt
[134] and the inhibitory HLH transcription factor Id2 [135].
In RORγ−/− and Id2−/− mice, LTi cells were absent resulting
in the complete lack of PPs and LNs [98, 134–136]. The
effect of Id2 on LTi cell development appears to be indirect
via suppressing E2A, an E protein transcription factor
promoting B cell development but limiting LTi cell and NK
cell development. In double mutant Id2−/−E2A−/− mice, LTi
cells, LNs, and PPs develop normally [137].
LTi cells originate from α4β7+ Il7r+ c-kit+ lin cells in the
fetal liver (FL) [138]. Il7r+ c-kit+ lin− FL cells were found
to give rise to all lymphoid lineages and LTi cells
suggesting that they corresponded to a common lymphoid
progenitor (CLP)-like cell [139]. In our hands, purified
α4β7+ Il7r+ c-kit+ lin− cells had lost the potential to
differentiate into B cells. It is possible that Il7r+ c-kit+ lin−
cells represent a heterogenous population comprising
already committed α4β7+ Il7r+ c-kit+ lin− LTi cells and
precursor cells harboring a CLP activity. Il7r+ c-kit+ FL
cells do not express LTαβ indicating that they lack
properties of mature LTi cells [95]. After exit from the FL
and entry into the fetal intestine, spleen, and putative sites
of LN development, they get exposed to local cytokines
such as Il7, which might induce further maturation and
expression of LTαβ (Fig. 6). In line with this, Il7
transcripts were found in the fetal gut already at E13 and
remained high until birth, whereas in the FL, only weak
levels of Il7 transcripts were detectable between E16 and 18
[140]. Il7 not only promotes the expression of LTαβ but
Fig. 6 Colonization of the
periphery with LTi precursor
cells from fetal liver
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also the differentiation of CD4− FL precursors and the
survival of both FL precursor and mature LTi cells [114,
129, 138, 139]. There is evidence that the expression of
CD4 starts in the periphery and that CD4− Il7r+ c-kit+ lin
cells exist, which have some properties comparable to LTi
cells, and might represent an intermediate between FL
precursors and fully differentiated LTi cells [95].
A LTi-like cell subset was recently identified in the
mesenteries and LNs of human fetuses [141]. These cells
express IL-7Rα and RORγt, LTαβ, and TRANCE but are
negative for CD4. Coculture with fetal mesenchymal cells
resulted in the upregulation of adhesion molecules on the
mesenchymal cells. This effect could be blocked by
inhibiting the LTβR and TNFR pathway suggesting that,
like LTi cells in fetal mice, human LTi cells were able to
induce the maturation of mesenchymal cells by signaling
through both LTβR and TNFR.
There is a debate if LTi cells are terminally differentiated
or still harbor the potential to differentiate into other
lineages. Initially, the commitment of murine LTi cells into
Ag-presenting cells (APCs) and natural killer (NK) cells
was described [101]. Using RORγt knockin mice express-
ing the enhanced green fluorescence protein under the
control of the RORγt promoter, it was reported that in
peripheral lymphoid tissue of fetal mice, RORγt was
almost exclusively expressed in LTi cells and not in any
other lineages [98]. This does not fully exclude the
possibility that LTi cells harbor the capacity to differentiate
into other lineages and that under noncompetitive con-
ditions, e.g., in immunodeficient mice, LTi cells can give
rise to NK cells and APCs. In mice and man, a
subpopulation of CD4− cells in the intestinal crypts express
RORγt and other markers characteristic for LTi cells [142].
Unlike LTi cells, however, these cells are NKp46+ [142–
145], a type 1 transmembrane protein found on NK cells.
NKp46+ cells have no conventional NK cell function such
as IFNγ or perforin production. Instead, they produce high
levels of Il22, a cytokine that has been shown to be
essential for host defense and epithelial cell homeostasis in
humans [143]. There is evidence for a developmental
relationship between LTi cells and RORγt+ NKp46+ NK-
like cells in mice and humans. Human LTi cells display
surface markers characteristic for NK cells [141]. In
addition, LTi cells in mice and man express Il22 and Il17
[141, 146]. As for mouse LTi cells, the commitment of
human LTi cells into NK cells was reported in vitro [141]
and a LTi-like subset isolated from the lamina proporia of
adult intestine gave rise to NK cells both in vitro and in
vivo [147]. The number of RORγt+ NK-like cells is
severely reduced in germfree mice, suggesting that the
intestinal microflora could influence their generation from a
precursor cell present in the intestine. The idea that either
LTi cells and NK cells originate from a bipolar precursor or
that LTi cells can give rise to NK cells is supported by the
findings that the HLH protein Id2 is required for the
development of both LTi cells and NK cells [137, 148].
Altogether, a developmental relationship of LTi and NK
cells is likely, and the generation of the cells might be
regulated by cytokines provided in the FL and intestine, as
well as by exposure to commensal bacteria.
There is evidence that LTi cells are not only generated
during fetal but also adult life and mainly persist in SLOs.
Adult CD4+CD3− cells were found in the spleen, LNs, PPs,
lamina propria, and in ILFs and CPs [149, 150]. The cells
share a transcript expression profile with fetal LTi cells and
were termed LTi-like cells [151]. In contrast to LTi cells,
however, adult LTi-like cells express OX40L and CD30L
after in vitro culture [152]. Coculture experiments with T
helper 2 cells and the in vivo colocalization with T cells let
to the hypothesis that they have a role for TH cells
promoting long-lived B cell responses [153]. In fact, the
Ag-driven expression of OX40 and CD30 on T cells allows
the receiving of survival signals from OX40L and CD30L-
expressing cells.
Mice deficient in RORγt lack adult LTi-like cells and
CPs suggesting that after birth, these cells contribute to the
generation and/or maintenance of CPs. Adoptive transfer
experiments have shown that the pool of adult LTi-like cells
in CPs and ILFs could be reconstituted by the transfer of
BM, indicating that adult BM can be the source of adult
LTi-like cells [70]. Similarly to the link between LTi-like
cells and CPs, the same cells can induce the formation of
ILFs in adult mice [4]. The effect of adult LTi-like cells was
further increased in the presence of LPS (Fig. 7). In a recent
report, LPS was shown to induce Il7 expression thereby
regulating T cell responses [154]. It is possible that the
Fig. 7 Mature lymphocytes, LTi cells, and microbial stimulation
shape the size and organization of intestinal lymphoid tissues after
birth. MC mesenchymal cell, DC dendritic cell, PP Peyer’s patch, CP
cryptopatch, ILF isolated lymphoid follicle
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number and activity of adult LTi-like cells is regulated by a
similar mechanism, since they are Il7-responsive cells.
Altogether, these data suggest that there is a link between
innate signals and generation of local sites for adaptive
immune responses in the gut. The effect of adult LTi-like
cells on stromal cells has also been shown in lymphocyte
choriomeningitis virus (LCMV)-infected mice. Here, the
adoptive transfer of BM into LCMV-infected mice led to
the accumulation of LTi-like cells in the spleen of recipient
mice, where they could help reorganizing the splenic
architecture by promoting the establishment of a normal
FRC network [155]. There are a number of open questions
that remain to be investigated. For example, the lineage
relationship between fetal LTi cells and adult LTi-like cells
and the identity of a BM precursor cell that gives rise to LTi
cells remain unknown. In addition, the signals that regulate
LTi-like cell generation and recruitment to the gut are still
unclear. Further studies in mouse models lacking adult LTi-
like cells will help to clarify their role for the generation of
inducible lymphoid tissue and adaptive immune responses
in the gut.
PP maturation in the postnatal life
The formation of PPs cannot be disrupted by injecting a
LTβR inhibitor (LTβR:Ig) after birth or by transgene
expression of LTβR:Ig postnatally, indicating that there is
a critical time window in which LTβR signaling is required
for PP development [156, 157]. In contrast, PPs are absent
in adult mice treated only once during fetal life with a
blocking LTβR-Ig fusion protein [93]. These data indicate
that the interruption of LT signaling during fetal develop-
ment has irreversible consequences for PP development and
cannot be compensated by the activity of lymphocytes in
adults. B, T, and NK cells arrive in the gut around E18.5. A
mature PP architecture with segregated B and T cell zones
is not achieved before 1 week after birth and is independent
of the presence of lymphocytes [96]. Similarly, in the
spleen, the cellular organization that directs T and B cells
into different compartments is already in place before the
entry of lymphocytes [158]. The maintenance of lymphoid
follicle architecture and the development of FDC networks
in adult PPs, however, require the presence of B cells
expressing TNF and LTαβ [159]. Indeed, activated B, T,
and NK cells express LTαβ [160], and it is therefore likely
that they can play a significant role in maintaining
lymphoid tissue architecture and organization in adult
SLOs. Interestingly, B cell follicles are maintained in LNs
of LTβR-Ig-treated adult mice despite the loss of FDC
networks [161]. Therefore, in contrast to PPs, LN B cell
follicle organization remains functionally independent of
LTβR signaling and FDC networks.
In the postnatal life, there is a relationship between the
maturation of PPs and antigenic stimulation (Fig. 7). If
animals are kept in a germ free environment, PPs remain
small and disorganized, but as soon as mice are exposed to
conventional or specific pathogen-free conditions, PPs
return to normal size and organization [162]. There is,
however, no evidence that the number of PPs increases
upon antigenic stimulation indicating that PP organogenesis
is developmentally fixed.
Importantly, intestinal infections with mouse mammary
tumor virus (MMTV), a retrovirus that is transmitted to the
pubs via milk, can accelerate PP maturation [163]. MMTV
enters the mucosa through infecting enterocytes and
probably also via M cells [164, 165]. After invasion of
intestinal lymphoid tissue, MMTV infects DC and B cells.
Infected DCs present a MMTV superantigen (Sag) to T
cells in PPs. The SAg-driven activation and amplification
of specific T cells is followed by T cell/B cell interaction
and GC formation [166]. In 10 days old pubs, Ig-producing
plasma cells formed large aggregates after MMTV infec-
tion, whereas in uninfected controls, follicles appear to be
still disorganized and small. It is not known if this MMTV-
driven maturation of lymphoid architecture is due to
programmed increase of B cells and/or an effect on
lymphoid stroma cells. The number of VCAM-1+ mesen-
chymal cells in MMTV-infected PPs is increased suggest-
ing that probably both the lymphocyte compartments and
the stroma cell niche are affected. Altogether, mature
lymphocytes and microbial stimulation can shape the size
and organization of PPs, but have no effect on the number
of PPs in mice after birth.
Induction of ILF formation
In germ-free mice, the spectrum of organized intestinal
lymphoid tissue comprises small PPs and hundreds of CPs,
which are detectable 1–2 weeks after birth [3]. Bacterial
colonization does not affect the overall number of intestinal
lymphoid tissues, but increases the number of ILFs to the
expense of CPs. These data strongly suggest that the
intestinal flora can stimulate the progression of CPs to
ILFs rather than the de novo generation of ILFs (Fig. 7).
The invariant localization of both structures in the gut
together with the observation that intermediates of CPs and
ILFs can be easily identified, let to the conclusion that ILFs
can emerge from CPs and that both represent a dynamic
pool of lymphoid aggregates termed “solitary intestinal
lymphoid structures” [27].
Bacteria are recognized by receptors for pathogen-
associated molecular patterns. Hence, the generation of
ILFs might be regulated via the activation of such innate
receptors. In line with this, the number of ILFs is decreased
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in TLR2/4-, Myd88-, TRIF-, and NOD2-deficient mice [2].
It was further demonstrated that the bacteria-driven transi-
tion of CPs into ILFs was mediated through the recognition
of Gram-negative probiotics by nucleotide-binding oligo-
merization domain containing 1 (NOD1) [2]. NOD1 is a
member of pattern recognition molecules that sense
bacterial products within the cytoplasm and is expressed
by intestinal epithelial cells [167]. After the immediate
production of proinflammatory cytokines and antimicrobial
factors by epithelial cells, a second line of defense might
involve the generation of ILFs serving as inductive sites for
pathogen-specific immune responses. Perhaps, the most
important role of commensal bacteria is to continuously
trigger the formation of ILFs in adults. In mice deficient for
activation-induced cytidine deaminase, an enzyme that
regulates class switch recombination, the absence of IgA
leads to an abnormal expansion of anaerobic bacteria [168].
These mice have a dramatic increase in the number of ILFs.
The ILF hyperplasia was reversible when the bacterial load
was reduced by antibiotics further illustrating the link
between microflora and ILF formation.
The epithelial and stromal-derived signals, which induce
the transition from CPs to ILFs after exposure to bacteria, are
unknown, but it is likely that factors regulating the recruitment
of lymphocytes play an essential role. The integrin α4β7
expressed by lymphocytes and the ligand MAdCAM-1
expressed by vascular endothelial cells are required for the
adherence of lymphocytes to HEVs of PPs [169]. In the
absence of β7 integrin, lymphocyte migration into PP is
abolished and the transition of CPs into ILFs is impaired
[170, 171]. Moreover, the colonization of CPs with B cells
requires CXCR5 [172] and CCR6 [173] expressed by B cells,
whereas CCR7 acts as a negative regulator of ILF formation
[3]. CCR6 has two known ligands, CCL20 expressed by the
FAE [109] and β-defensin 3 (mBD3) found in inflamed
epithelia and in crypts [174, 175]. The reduction of ILFs in
mBD3-deficient mice and in animals treated with blocking
anti-CCL20 Abs suggest that both CCR6 ligands have a
nonredundant function in ILF formation. CCR6 is expressed
by mature B cells, subsets of CD4 and CD8 T cells as well as
CD11b+ myeloid DCs [51]. It is possible that both the
activation and recruitment of lymphocytes and DCs is
affected in mice lacking CCR6 signals.
In addition to bacterial stimuli, LTβR signaling is
essential for the generation and maintenance of ILFs, and
ILFs and CPs can be induced in LTα−/− mice lacking such
structures by transplantation of WT BM [22, 24, 70]. In
utero treatment of mice with LTβR-Ig, however, did not
prevent the development of ILFs illustrating that the LTβR-
dependent formation of ILFs occurred after birth [21, 22].
Unlike PP, ILFs require continuous LTβR signaling for
maintenance through adulthood, since treatment of adult
mice with LTβR-Ig abolishes ILFs but not PPs [176]. The
development and maintenance of ILFs in adults was also
shown to depend on TNFRI [22, 177]. Finally, another
mutation that can lead to the absence of CPs and ILFs is the
deficiency of RORγt [149]. As previously reported, these
mice lack fetal LTi cells and have no apparent LTi-like cells
in the adult intestine. Since CPs mainly consist of RORγ+
LTi-like cells, it was possible that adult LTi-like cells were
the source of LTβ thereby initiating the development of
CPs after birth, before or during bacterial stimuli promoted
the maturation of these structures into ILFs. This question
has been directly addressed by reconstituting RORγ-
deficient mice with adult LTi-like cells [4]. In these mice,
the formation of CPs and ILFs as well as the number of IgA
plasma cells was considerably restored. In addition, it was
shown for the first time that the activity of adult LTi-like
cells was augmented by bacterial stimuli. The interaction of
LTi-like cells with stromal cells augmented the production
of CCL20 and BAFF, a TNF family member molecule
involved in the proliferation of B cells and the survival of
plasma cells. This study explains the dynamic crosstalk
between bacteria, nonhematopoietic and hematopoietic
cells in preexisting CPs leading to the generation of mature
ILFs and to local IgA synthesis. Altogether, the generation of
ILFs requires LTi-like cells, LTβR and TNF-R-expressing
stromal cells, bacteria, and the integrin and chemokine-
dependent influx of mature lymphocytes. The maintenance
of ILFs in the gut by commensal bacteria and LTβR
signaling might be protective in generating immunogenic
or tolerogenic responses. In line with this, with the aim of
commensal bacteria, the progression of intestinal inflamma-
tion could be inhibited [178].
Role of gut-associated lymphoid tissue
for the development of IBD
Human inflammatory bowel disease (IBD) including
Crohn’s disease and colitis ulcerosa is a multifactorial
disease that is characterized by aberrant cytokine expres-
sion, leukocyte infiltration, inflammation, and tissue dam-
age. Since the GALT is required for priming or tolarizing
Ag-specific intestinal T cells, a link between GALT
dysfunction and IBD has been proposed. Various studies
in mice have addressed this question by studying the
development of colitis in GALT-deficient mice. Dependent
on the model used, GALT were either protective or
nonprotective for the development of chronic intestinal
inflammation. Mice with a targeted disruption of Gαi2, a
candidate gene for IBD, or RA-inducible gene I, a regulator
of Gαi2, had a significantly reduced number and size of
PPs and were susceptible to DSS-induced colitis [179–181].
The disease was more active in mice deficient for both
mesenteric LNs and PPs than in mice lacking only PP
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[182]. Elimination of GALT with LTβR-Ig prevented mice
from a Th1-type CD45RBhi-driven [183] and a Th2-
mediated form of experimental colitis but had no effect on
Th1-type TNBS-induced colitis [184]. Collectively, it can
be assumed that mesenteric LNs can have a role in
controlling intestinal inflammation, probably through in-
duction of peripheral tolerance mechanisms.
Both LTαβ and LIGHT are ligands for LTβR and the
overexpression of these molecules is associated with the
development of various autoimmune diseases including
colitis and the de novo formation of ectopic lymphoid
tissues [185]. These so-called tertiary lymphoid organs
(TLO) show remarkable similarities with normal SLOs to
form an organized microarchitecture and to mount T and B
cell responses [7, 8]. Indeed, increased numbers of
lymphoid follicles are detectable in the human intestine
under inflammatory conditions, including IBD [186]. The
pathogenetic role of lymphoid neogenesis is not fully
understood but it is possible that TLOs provide the
infrastructure for Ag-driven clonal expansion, accumulation
of activated T and B cells, and chronic autoimmune
responses. The formation of HEVs and the expression of
adressins and chemokines in TLOs might lead to massive
influx with leukocytes resulting in escalation of the
inflammatory disease. In line with this, MAdCAM-1, an
addressin found on endothelial cells of GALT HEVs, is
aberrantly upregulated in chronically inflamed intestines of
patients with IBD [187], and blocking of the α4β7/
MAdCAM-1 pathway has been developed as a therapeutic
strategy to treat IBD [188, 189]. In mucosal IBD lesions,
CXCL13, a chemokine playing an important role in normal
GALT development, was found [190]. The ectopic expres-
sion of CXCL13 can induce TLO development [191]
suggesting that the aberrant CXCL13 expression in the
inflamed gut of IBD patients might contribute to the
formation of irregular lymphoid aggregates. Altogether,
chronic inflammatory conditions can lead to the aberrant
expression of lymphoid adhesion molecules and chemo-
kines followed by the abnormal recruitment and persistence
of leukocytes.
Numerous cytokines contribute to the homeostatic
regulation of the mucosal immune system [192]. The
cytokine-driven pathways which orchestrate T cell priming,
differentiation, and survival in the GALT might influence
the balance between tolerance and immunity in the
intestine. Here, DCs have a key role in eliciting immune
responses and preventing inflammation. For example, the
production of RA by DCs in PPs mediates the generation of
gut-homing IgA-secreting B cells and gut-homing T cells
and, on the other hand, the differentiation of naïve T cells
into regulatory T cells [36, 193, 194]. The Il7-like cytokine
TSLP produced by intestinal epithelial cells can stimulate
subepithelial DCs to produce Il10 [195]. Hence, these
“conditioned” DCs may stabilize a noninflammatory
protective Th2-type response in PP, unless an infection
occurs, which generates a rather proinflammatory environ-
ment. In a mouse model of IBD, TSLPR−/− mice exhibited
an increased severity of inflammation, which was correlated
with increased levels of proinflammatory cytokines [196].
TSLP might therefore have an immunoregulatory role for
preventing the development of a Th1-mediated colitis.
Interestingly, the inflammatory cytokines Il1β and TNF-α,
as well as TLR stimulation, can induce TSLP expression in
human airway epithelial cells via activation of NF-κB [197,
198]. This cytokine-driven induction of TSLP secretion
might represent a mechanism to self-limit inflammation at
epithelial surfaces. Il7 and SCF, two pleiotropic cytokines
with activity of B cell growth and T cell homeostasis, are
produced by various nonhematopoietic cells including
intestinal epithelial cells [199, 200]. Inflammatory signals
and bacterial pathogens can induce Il7 and SCF production
by enterocytes, which might indirectly stimulate B and T
cell responses. Indeed, studies in Il7 tg mice revealed that
there is a link between expression of Il7 in the colonic
epithelium and development of chronic colitis [201].
Furthermore, Il7 was shown to be essential for the
development and persistence of colitis in an inflammatory
bowel disease model where colitogenic T cells were
adoptively transferred into syngenic RAG−/− mice [202].
Notably, in this model, systemic rather than intestinal Il7
was required for the development of the disease [203]. In
mice expressing Il7tg ubiquitously (H-Il7 mice) already
before birth, we observe a large increase in PPs and
additional colonic patches [129]. These mice did not
develop IBD spontaneously, although we cannot fully
exclude that the reconstitution of H-Il7 mice with colito-
genic T cells could cause an exacerbated intestinal
inflammation. Since in H-Il7 animals, the number of Il7r-
expressing B, T, and LTi cells is strikingly increased, the
activity of Il7 in the gut might be rather low through high
consumption of Il7. Collectively, the proportion of protec-
tive and proinflammatory cytokines are key factors in
polarizing intestinal DCs, which determines T cell priming
in the GALT and disposition of developing chronic colitis.
Concluding remarks
In the last decade, studies in mice on the molecular program
that controls PP development have led to a paradigm that
two cellular subsets, lymphoid tissue inducer and organizer
cells, are key players in the framework of signals for
organogenesis. The identification of LTi-like cells in adult
mice and in humans had led to a new concept where these
cells have a broader role in establishing and maintaining
lymphoid compartments and immune responses. In addition
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to organizer cells, LTi cells have the potential to interact
with other hematopoietic and nonhematopoietic subsets
such as endothelial and epithelial cells. They can be
stimulated upon inflammatory signals and, due to their
operative role as lymphoid tissue inducers, may regulate
immunosurveillance against pathogens. Finally, the obser-
vations that IgA+ lymphoid follicles can form upon
bacterial colonization and inflammation in the gut add
new information on the dynamic process of lymphoid tissue
formation and the role of the innate immune system in
generating adaptive immune responses.
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